Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
Steurer, Michael, Montillo, Marco, Scarfò, Lydia, Mauro, Francesca R., Andel, Johannes, Wildner, Sophie, Trentin, Livio, Janssens, Ann, Burgstaller, Sonja, Frömming, Anna, Dümmler, Thomas, Riecke, Kai, Baumann, Matthias, Beyer, Diana, Vauléon, Stéphanie, Ghia, Paolo, Foà, Robin, Caligaris-Cappio, Federico, Gobbi, Marco
Published in Haematologica (Roma) (01.10.2019)
Published in Haematologica (Roma) (01.10.2019)
Get full text
Journal Article
Single and Repeated Dose First-in-Human Study with the Anti-Hepcidin Spiegelmer Nox-H94
Riecke, Kai, Zöllner, Stefan, Boyce, Malcolm, Vauléon, Stephanie, Swinkels, Dorine W., Dümmler, Thomas, Summo, Luciana, Laarakkers, Coby, Schwoebel, Frank, Fliegert, Frank
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Phase IIa Study of the Anti-CXCL12/SDF-1 Spiegelmer® Nox-A12 Alone and Combined with Bendamustine/Rituximab in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)
Gobbi, Marco, Caligaris-Cappio, Federico, Montillo, Marco, Vauléon, Stephanie, Zöllner, Stefan, Dümmler, Thomas, Kruschinski, Anna, Fliegert, Frank
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Results from a Phase IIa Study of the Anti-CXCL12 Spiegelmer Olaptesed Pegol (NOX-A12) in Combination with Bendamustine/Rituximab in Patients with Chronic Lymphocytic Leukemia
Steurer, Michael, Montillo, Marco, Scarfò, Lydia, Mauro, Francesca Romana, Andel, Johannes, Wildner, Sophie, Trentin, Livio, Janssens, Ann, Burgstaller, Sonja, Kruschinski, Anna, Dümmler, Thomas, Riecke, Kai, Ghia, Paolo, Caligaris-Cappio, Federico, Gobbi, Marco
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Final Results from the Phase IIa Study of the Anti-CXCL12 Spiegelmer® Olaptesed Pegol (NOX-A12) in Combination with Bortezomib and Dexamethasone in Patients with Multiple Myeloma
Ludwig, Heinz, Weisel, Katja, Petrucci, Maria Teresa, Leleu, Xavier, Cafro, Anna Maria, Laurent, Garderet, Zojer, Niklas, Foa, Robin, Greil, Richard, Yakoub-Agha, Ibrahim, Kruschinski, Anna, Dümmler, Thomas, Riecke, Kai, Engelhardt, Monika
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Anti-CXCL12/SDF-1 Spiegelmer® Nox-A12 Alone and In Combination With Bortezomib and Dexamethasone In Patients With Relapsed Multiple Myeloma: Results From A Phase IIa Study
Ludwig, Heinz, Weisel, Katja, Engelhardt, Monika, Greil, Richard, Cafro, Anna Maria, Petrucci, Maria Teresa, Dümmler, Thomas, Zöllner, Stefan, Zeitler, Stefan, Riecke, Kai, Kruschinski, Anna
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Anti-CXCL12/SDF-1 Spiegelmer® Nox-A12 Alone and In Combination With Bendamustine and Rituximab In Patients With Relapsed Chronic Lymphocytic Leukemia (CLL): Results From A Phase IIa Study
Gobbi, Marco, Steurer, Michael, Caligaris-Cappio, Federico, Montillo, Marco, Janssens, Ann, Trentin, Livio, Dümmler, Thomas, Zöllner, Stefan, Zeitler, Stefan, Riecke, Kai, Kruschinski, Anna
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article